18 research outputs found
Characterization of mouse major urinary protein genes
Major urinary protein (MUP) genes were isolated from C57 genomic libraries, characterized by restriction enzyme mapping and compared with MUP genes isolated from BALB/c genomic libraries (Clark et al, 1982; Bishop et al, 1982). The conclusions drawn from the characterization of this new set of MUP genes are in agreement with those previously drawn from studies on the BALB/c MUP genes.Most MUP genes were found to share extensive homology in their transcription units and 5' and 3' flanking regions. Exceptions were those genes whose coding regions have been interupted by insertions and/or deletions. The MUP genes fall into two main groups based on hybridization criteria: group 1 and group 2 (Bishop et al, 1982). With the exception of one group 2 gene (BL-25/CL-2), restriction site homology was found to be greater within groups than between than. Restriction site homologies further divided the group 1 genes into two sub-groups. Sequence data revealed that the two sub-groups have different forms of an A-rich region located M0bp upstream of the TATA box.Messenger RNA from tissues that express MUP was shown to be more homologous to group 1 coding sequences than to group 2 coding sequences. In the liver, two forms of MUP mRNA can be distinguished. Group 1 sequences hybridized preferentially to the abundantly transcribed long form of the mRNA, while group 2 sequences hybridized preferentially to the short and rarer form of the mRNA.
Genomic digests illustrated that two types of variation are found between the MUP genes of BALB/c and C57BL/Fa mice. The first relates to the presence of variant restriction fragments. Two cloned MUP genes carrying such fragments were identified. The second relates to variation in the intensity of common restriction fragments. Differences between the strains in the total number of MUP genes were not observed. Variation in the intensity of common restriction fragments are proposed to be the result of different homogenization events that took place in the mouse lineages from which BALB/c and C57BL/Fa were derived
C-reactive protein is essential for innate resistance to pneumococcal infection
Summary: No deficiency of human C-reactive protein (CRP), or even structural polymorphism of the protein, has yet been reported so its physiological role is not known. Here we show for the first time that CRP-deficient mice are remarkably susceptible to Streptococcus pneumoniae infection and are protected by reconstitution with isolated pure human CRP, or by anti-pneumococcal antibodies. Autologous mouse CRP is evidently essential for innate resistance to pneumococcal infection before antibodies are produced. Our findings are consistent with the significant association between clinical pneumococcal infection and non-coding human CRP gene polymorphisms which affect CRP expression. Deficiency or loss of function variation in CRP may therefore be lethal at the first early-life encounter with this ubiquitous virulent pathogen, explaining the invariant presence and structure of CRP in human adults
A specific nanobody prevents amyloidogenesis of D76N \u3b22-microglobulin in vitro and modifies its tissue distribution in vivo
Systemic amyloidosis is caused by misfolding and aggregation of globular proteins in vivo for which
effective treatments are urgently needed. Inhibition of protein self-aggregation represents an attractive
therapeutic strategy. Studies on the amyloidogenic variant of \u3b22-microglobulin, D76N, causing
hereditary systemic amyloidosis, have become particularly relevant since fibrils are formed in vitro in
physiologically relevant conditions. Here we compare the potency of two previously described inhibitors
of wild type \u3b22-microglobulin fibrillogenesis, doxycycline and single domain antibodies (nanobodies).
The \u3b22-microglobulin -binding nanobody, Nb24, more potently inhibits D76N \u3b22-microglobulin
fibrillogenesis than doxycycline with complete abrogation of fibril formation. In \u3b22-microglobulin knock
out mice, the D76N \u3b22-microglobulin/ Nb24 pre-formed complex, is cleared from the circulation at the
same rate as the uncomplexed protein; however, the analysis of tissue distribution reveals that the
interaction with the antibody reduces the concentration of the variant protein in the heart but does
not modify the tissue distribution of wild type \u3b22-microglobulin. These findings strongly support the
potential therapeutic use of this antibody in the treatment of systemic amyloidosis
Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity
Notch signaling is central to vertebrate development, and analysis of Notch has provided important insights into pathogenetic mechanisms in the CNS and many other tissues. However, surprisingly little is known about the role of Notch in the development and pathology of Schwann cells and peripheral nerves. Using transgenic mice and cell cultures, we found that Notch has complex and extensive regulatory functions in Schwann cells. Notch promoted the generation of Schwann cells from Schwann cell precursors and regulated the size of the Schwann cell pool by controlling proliferation. Notch inhibited myelination, establishing that myelination is subject to negative transcriptional regulation that opposes forward drives such as Krox20. Notably, in the adult, Notch dysregulation resulted in demyelination; this finding identifies a signaling pathway that induces myelin breakdown in vivo. These findings are relevant for understanding the molecular mechanisms that control Schwann cell plasticity and underlie nerve pathology, including demyelinating neuropathies and tumorigenesi
Intraspecific evolution of a gene family coding for urinary proteins
The genome of the laboratory mouse contains about 35 major urinary protein (MUP) genes, many of which are clustered on chromosome 4. We have used distance and parsimony methods to estimate phylogenetic relationships between MUP genes from nucleotide sequence and restriction maps. By analyzing coding sequences we show that the genes fall into four main groups of related sequences (groups 1–4). Comparisons of restriction maps and the nucleotide sequences of hypervariable regions that lie 50 nucleotides 5′ to the cap sites show that the group 1 genes and probably also the group 2 pseudogenes fall into subgroups. The most parsimonious trees are consistent with the evolution of the array of group 1 and 2 genes by mutation accompanied by a process tending toward homogenization such as unequal crossing-over or gene conversion. The phylogenetic grouping correlates with grouping according to aspects of function. The genomes of the inbred strains BALB/c and C57BL contain different MUP gene arrays that we take to be samples from the wild population of arrays
Type II PI4-kinases control Weibel-Palade body biogenesis and von Willebrand factor structure in human endothelial cells
Weibel-Palade bodies (WPBs) are endothelial storage organelles that mediate the release of molecules involved in thrombosis, inflammation and angiogenesis, including the pro-thrombotic glycoprotein von Willebrand factor (VWF). Although many protein components required for WPB formation and function have been identified, the role of lipids is almost unknown. We examined two key phosphatidylinositol kinases that control phosphatidylinositol 4-phosphate levels at the trans-Golgi network, the site of WPB biogenesis. RNA interference of the type II phosphatidylinositol 4-kinases PI4KIIα and PI4KIIβ in primary human endothelial cells leads to formation of an increased proportion of short WPB with perturbed packing of VWF, as exemplified by increased exposure of antibody-binding sites. When stimulated with histamine, these cells release normal levels of VWF yet, under flow, form very few platelet-catching VWF strings. In PI4KIIα-deficient mice, immuno-microscopy revealed that VWF packaging is also perturbed and these mice exhibit increased blood loss after tail cut compared to controls. This is the first demonstration that lipid kinases can control the biosynthesis of VWF and the formation of WPBs that are capable of full haemostatic function